QUALITY ASSESSMENT OF VARIOUS BRANDS OF CEFIXIME 400 MG CAPSULES AVAILABLE IN YEMENI MARKET
DOI:
https://doi.org/10.22159/ijap.2025v17i1.51714Keywords:
Cefixime, 400-mg capsules, Quality, Specification, Yemeni marketAbstract
Objective: The study aimed to assess the quality control of different brands of cefixime 400 mg capsule brands available in Yemeni drug market.
Methods: The pharmacopeial specifications of five cefixime 400 mg capsule brands available in Yemeni drug market including two domestic brands, were assessed in this study. Assessment included assay content, capsule weight variation and disintegration. In addition, drug dissolution and antimicrobial activity test were assessed.
Results: Out of five brands, three brands of cefixime 400 mg capsules passed official specified assay tests according to United States Pharmacopeia (USP) specifications. The five brands showed a similar profile of weight variation and drug disintegration that were within the limits. However, the results of drug content for five brands showed in range 78.78- 104.46 % in which three brands (B, D & E) in compliance to USP specification (90-110%) and two brands (A & C) not compliance to USP specification. Also, the results of dissolution profile were in range 86.2- 109.8% for four brands (A, B, D & E) that compliance to USP specifications, and 73.56% for the brand C that was not compliance to USP specifications.
Conclusion: Based on the results obtained in this study, the drug content for three brands (B, D, E) is within the pharmacopeial limit, but the drug content of (A, C) is out of the limit. while the capsule disintegration, weight variations, and antibacterial activity in all tested brands are within pharmacopeial limit. The dissolution profile for four brands (A, B, D, E) is within the pharmacopeial limit, but the dissolution profile for (C) is less than the allowed limit.
Downloads
References
Bano R, Gauhar S, Naqvi SBS., et al., Pharmaceutical evaluation of different brands of levofloxacin tablets (250 mg) available in local market of Karachi (Pakistan). Int. J. Curr. Pharm. Res, 2011. 3(1): p. 15-22. https://www.innovareacademics.in/journal/ijcpr/Issues/Vol3Issue1/244.pdf
Adam D, Hostalek U, and Tröster K, 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Infection, 1995. 23(Suppl 2): p. S83-S86. https://link.springer.com/article/10.1007/BF01742990
McMillan A, and Young H, The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime. Int J STD AIDS, 2007. 18(4): p. 253-254. https://doi.org/10.1258/095646207780658971
Dressman JB. Amidon GL, Reppas C, et al., Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res, 1998. 15: p. 11-22. https://link.springer.com/article/10.1023/A:1011984216775
Alsaifi A., Comparative evaluation quality of different brands of ibuprofen 400 mg tablets available in Yemeni’s Market. Chron Pharm Sci, 2018. 3: p. 730-742. https://scientiaricerca.com/srcops/SRCOPS-02-00072.php
Al-kershi F.A, Othman G.Q., and Al-qadasi F.A, Quality and stability of amoxicillin-potassium clavulanate drugs marketed in Yemen: influence of tropical storage conditions. J Chem Pharm Res, 2016. 8: p. 160-166. https://www.jocpr.com/abstract/quality-and-stability-of-amoxicillinpotassium-clavulanate-drugs-marketed-in-yemen-influence-of-tropical-storage-conditio-4833.html
Alyahawi A. and Alsaifi. A, Quality control assessment of different brands of ciprofloxacin 500 mg tablets in Yemen. Univ J Pharm Res, 2018. 3(4): p. 31-36. https://www.semanticscholar.org/paper/QUALITY-CONTROL-ASSESSMENT-OF-DIFFERENT-BRANDS-OF-Alyahawi-
Albaser NA, Al-Ghani A.M, and Thabit A.A., In vitro Comparative Quality Assessment of Four Brands of Moxifloxacin 400 mg Tablets Marketed in Yemen. Al-Razi Un J Med Sci, 2021. 5(1). https://doi.org/10.51610/rujms5.1.2021.97
Thabit A AM and AL-Ghani AM, In Vitro Cefixime Dissolution in Pharmacopeia-Recommended Medium and Simulated Gastrointestinal Fluids: A Comparative Study. IN VITRO. Asian J Pharm Clin Res, 2019. 12(12). https://doi.org/10.22159/ajpcr.2019.v12i12.35966
Othman GA.-W, Y. M. Battah M M, Halboup AM,. et al, Comparative study of seven brands of levofloxacin 500 mg film-coated tablet marketed in Yemen. Int J App Pharm, 2021. 13(2): p. 264-268. https://doi.org/10.22159/IJAP.2021V13I2.40217
The United States Pharmacopeia (USP 43),National Formulary (NF 38). 2020, Rockville,MD.
Ali, B.A., M.G. Al-haddad, and A.A. Areqi, Comparative Evaluation of Some Commercial Clopidogrel Tablets Available in Yemen. Majalah Farmaseutik, 2018. 13(2): p. 79-87. https://doi.org/10.22146/farmaseutik.v13i2.40917
Osei YA, Boakye EO, Bayor MT., et al., Physicochemical equivalence and quality assessment of various brands of gastro-resistant omeprazole capsules in the Kumasi metropolis. Sci World J, 2022. 2022. https://doi.org/10.1155/2022/7924600
Chen W., Stithit S., and Zheng J., Specification setting and manufacturing process control for solid oral drug products, in Developing Solid Oral Dosage Forms. 2017, Elsevier. p. 677-693. https://doi.org/10.1016/B978-0-12-802447-8.00025-X
Shahnaz, G., Shahnaz G., Arshad HM., Shyum NSB., et al., Pharmaceutical evaluation of commercial brands of cefixime 400 mg capsules marketed in Karachi (Pakistan). J. Pharm. Res, 2009. 8: p. 98-104. https://dx.doi.org/10.18579/jpcrkc/2009/8/2/79774
Ejike, U.S. and Tareka-Akpo E., Ultraviolet spectrophotometric determination of cefixime content in some pharmaceutical brands available in the Nigerian market. An Int J Advances Pharm sci. 2013. 6: p. 2757-59. https://www.semanticscholar.org/paper/ULTRAVIOLET-SPECTROPHOTOMETRIC-EVALUATION-OF-BRANDS/09bfea8ae7ff70ccccd7c2da0c4f4ef4785d5e0b
Published
How to Cite
Issue
Section
Copyright (c) 2024 AHMED M. AL-GHANI, MOHAMMED ALKHAWLANI, AMIN ALWOSABI, ABDULLAH A. ALBEGALI, ANES A. M. THABET
This work is licensed under a Creative Commons Attribution 4.0 International License.
